FONS APONI : SACRO E PROFANO TRA ANTICHITÀ E MEDIOEVOZANOVELLO, Paola.Collection de l'Ecole française de Rome. 2007, Vol 383, issn 0223-5099, 345-364, 424 [29 p.]Conference Paper

Tumor-induced immune dysfunctions caused by myeloid suppressor cellsBRONTE, Vincenzo; SERAFINI, Paolo; APOLLONI, Elisa et al.Journal of immunotherapy (1997). 2001, Vol 24, Num 6, pp 431-446, issn 1524-9557Article

Immunotherapy for EBV-associated malignancies : PIH: Cancer immunologyMERLO, Anna; TURRINI, Riccardo; DOLCETTI, Riccardo et al.International journal of hematology. 2011, Vol 93, Num 3, pp 281-293, issn 0925-5710, 13 p.Article

Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transferTURRINI, Riccardo; MERLO, Anna; DOLCETTI, Riccardo et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 11, pp 1639-1645, issn 0340-7004, 7 p.Article

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cellsMARIGO, Ilaria; DOLCETTI, Luigi; SERAFINI, Paolo et al.Immunological reviews. 2008, Vol 222, pp 162-179, issn 0105-2896, 18 p.Article

Formation and antitumor activity of PNUu-159682, a major metabolite of Nemorubicin in Human liver microsomesQUINTIERI, Luigi; GERONI, Cristina; FANTIN, Marianna et al.Clinical cancer research. 2005, Vol 11, Num 4, pp 1608-1617, issn 1078-0432, 10 p.Article

Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytesUGEL, Stefano; SCARSELLI, Elisa; MUSIANI, Piero et al.Blood. 2010, Vol 115, Num 7, pp 1374-1384, issn 0006-4971, 11 p.Article

Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor a usage by melanoma-specific CD8⁺ T lymphocytesDE PALMA, Raffaele; MARIGO, Maria; ZANOVELLO, Paola et al.Cancer research (Baltimore). 2004, Vol 64, Num 21, pp 8068-8076, issn 0008-5472, 9 p.Article

Derangement of immune responses by myeloid suppressor cellsSERAFINI, Paolo; DE SANTO, Carmela; MARIGO, Ilaria et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 2, pp 64-72, issn 0340-7004, 9 p.Article

MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardiaZAMBON, Annalisa; MANDRUZZATO, Susanna; PARENTI, Anna et al.Cancer. 2001, Vol 91, Num 10, pp 1882-1888, issn 0008-543XConference Paper

Glycolytic Phenotype and AMP Kinase Modify the Pathologic Response of Tumor Xenografts to VEGF NeutralizationNARDO, Giorgia; FAVARO, Elena; SATTLER, Ulrike et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 12, pp 4214-4225, issn 0008-5472, 12 p.Article

Common cancer biomarkersBASIL, Christopher F; YINGDONG ZHAO; TAYLOR, Phil R et al.Cancer research (Baltimore). 2006, Vol 66, Num 6, pp 2953-2961, issn 0008-5472, 9 p.Article

MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomasDALERBA, Piero; FRASCELLA, Emanuela; MACINO, Beatrice et al.International journal of cancer. 2001, Vol 93, Num 1, pp 85-90, issn 0020-7136Article

Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150GHISI, Margherita; CORRADIN, Alberto; DE BELLIS, Gianluca et al.Blood. 2011, Vol 117, Num 26, pp 7053-7062, issn 0006-4971, 10 p.Article

IFN-γ-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancerMARTINI, Matteo; TESTI, Maria Grazia; KRAMPERA, Mauro et al.Vaccine. 2010, Vol 28, Num 20, pp 3548-3557, issn 0264-410X, 10 p.Article

HYTAD1-p20 : A new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancerROSATO, Antonio; BANZATO, Alessandra; DE LUCA, Gilda et al.Urologic oncology. 2006, Vol 24, Num 3, pp 207-215, issn 1078-1439, 9 p.Article

Identification of a CD 11b⁺/Gr-1⁺/CD31⁺ myeloid progenitor capable of activating or suppressing CD8⁺ T cellsBRONTE, Vincenzo; APOLLONI, Elisa; CABRELLE, Anna et al.Blood. 2000, Vol 96, Num 12, pp 3838-3846, issn 0006-4971Article

A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cellsSOLITO, Samantha; FALISI, Erika; GARRETT-MAYER, Elizabeth et al.Blood. 2011, Vol 118, Num 8, pp 2254-2265, issn 0006-4971, 12 p.Article

A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent In vivo Therapeutic ActivityBANZATO, Alessandra; BOBISSE, Sara; ROSATO, Antonio et al.Clinical cancer research. 2008, Vol 14, Num 11, pp 3598-3606, issn 1078-0432, 9 p.Article

Survivin in esophageal cancer : An accurate prognostic marker for squamous cell carcinoma but not adenocarcinomaROSATO, Antonio; PIVETTA, Michela; ZANOVELLO, Paola et al.International journal of cancer. 2006, Vol 119, Num 7, pp 1717-1722, issn 0020-7136, 6 p.Article

The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 env product of an endogenous retroviruslROSATO, Antonio; DALLA SANTA, Silvia; ZANOVELLO, Paola et al.Cancer research (Baltimore). 2003, Vol 63, Num 9, pp 2158-2163, issn 0008-5472, 6 p.Article